These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3404813)

  • 1. Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria.
    Coe FL; Parks JH; Bushinsky DA; Langman CB; Favus MJ
    Kidney Int; 1988 Jun; 33(6):1140-6. PubMed ID: 3404813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary saturation measurements in calcium nephrolithiasis.
    Weber DV; Coe FL; Parks JH; Dunn MS; Tembe V
    Ann Intern Med; 1979 Feb; 90(2):180-4. PubMed ID: 443649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichlormethiazide and oral phosphate therapy in patients with absorptive hypercalciuria.
    Insogna KL; Ellison AS; Burtis WJ; Sartori L; Lang RL; Broadus AE
    J Urol; 1989 Feb; 141(2):269-74. PubMed ID: 2913343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responsiveness of hypercalciuria to thiazide in Dent's disease.
    Raja KA; Schurman S; D'mello RG; Blowey D; Goodyer P; Van Why S; Ploutz-Snyder RJ; Asplin J; Scheinman SJ
    J Am Soc Nephrol; 2002 Dec; 13(12):2938-44. PubMed ID: 12444212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not.
    Ettinger B; Citron JT; Livermore B; Dolman LI
    J Urol; 1988 Apr; 139(4):679-84. PubMed ID: 3280829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorthalidone with potassium citrate decreases calcium oxalate stones and increases bone quality in genetic hypercalciuric stone-forming rats.
    Krieger NS; Asplin J; Granja I; Chen L; Spataru D; Wu TT; Grynpas M; Bushinsky DA
    Kidney Int; 2021 May; 99(5):1118-1126. PubMed ID: 33417997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorthalidone Is Superior to Potassium Citrate in Reducing Calcium Phosphate Stones and Increasing Bone Quality in Hypercalciuric Stone-Forming Rats.
    Krieger NS; Asplin JR; Granja I; Ramos FM; Flotteron C; Chen L; Wu TT; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2019 Jul; 30(7):1163-1173. PubMed ID: 31101664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of long-term chlorthalidone on stone formation and stone growth, intestinal absorption of calcium and secretion of parathyroid hormone in idiopathic hypercalciuria.
    Lockefeer JH; Juttmann JR; Birkenhäger JC
    Neth J Med; 1977; 20(6):257-62. PubMed ID: 609363
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder.
    Coe FL
    Ann Intern Med; 1977 Oct; 87(4):404-10. PubMed ID: 907239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of proximal tubule in the hypocalciuric response to thiazide of patients with idiopathic hypercalciuria.
    Bergsland KJ; Worcester EM; Coe FL
    Am J Physiol Renal Physiol; 2013 Aug; 305(4):F592-9. PubMed ID: 23720347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M; Ikegami M; Kiwamoto H; Umekawa T; Ishikawa Y; Kohri K; Kurita T
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diuretic treatment of recurrent nephrolithiasis caused by idiopathic hypercalciuria].
    Birkenhäger JC; Lockefeer J; Bakker NJ
    Ned Tijdschr Geneeskd; 1972 Aug; 116(33):1485-6. PubMed ID: 5069838
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
    Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
    Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Optimal dosage of chlorthalidone in the prevention of the recurrence of nephrolithiasis is 25 mg per day].
    Jaeger P; Portmann L; Jacquet AF; Bugnon JM; Burckhardt P
    Schweiz Med Wochenschr; 1986 Mar; 116(10):305-8. PubMed ID: 3961448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenesis of idiopathic hypercalciuria: evidence for parathyroid hyperfunction.
    Evans RA; Hills E; Wong SY; Wyndham LE; Eade Y; Dunstan CR
    Q J Med; 1984; 53(209):41-53. PubMed ID: 6324269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorthalidone improves vertebral bone quality in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Willett T; Asplin JR; Culbertson C; Che SP; Grynpas M
    J Bone Miner Res; 2011 Aug; 26(8):1904-12. PubMed ID: 21351146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis.
    Coe FL; Kavalach AG
    N Engl J Med; 1974 Dec; 291(25):1344-50. PubMed ID: 4610395
    [No Abstract]   [Full Text] [Related]  

  • 20. Relation between calcium oxalate hydrate form found in renal calculi and some urinary parameters.
    Conte A; Genestar C; Grases F
    Urol Int; 1990; 45(1):25-7. PubMed ID: 2305491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.